Team Grant : Netherlands-Canada Type 2 Diabetes Research Consortium- Pre-Proposal
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: Inquire with Unit
Memorial Deadline: RGCS review not required for Pre-Proposal Submission
External Deadline: Tuesday 25th, February 2020
Description
SIRI will be offering support with application development for this opportunity. Prospective applicants are encouraged to contact Jennifer Stevens (v5js@mun.ca) early during the development process to discuss the services available to them.
Much has been learned about the pathogenesis of type 2 diabetes and important new treatments have been generated over the past century; however, the prevalence of type 2 diabetes is increasing dramatically as are the associated complications. CIHR, ZonMw, the Dutch Diabetes Research Foundation (Diabetes Fonds), and Health~Holland are working in partnership to accelerate research and development to improve the lives of people with type 2 diabetes in Canada and the Netherlands by supporting one (1) internationally competitive and innovative Netherlands-Canada Type 2 Diabetes Research Consortium.
The Netherlands-Canada Type 2 Diabetes Research Consortium will support the formation of one international Consortium between Dutch researchers funded through the Diabetes II Breakthrough Projects, for-profit private parties and other private parties, and Canadian researchers, and will leverage the expertise of type 2 diabetes researchers in both countries. The 20 Dutch Diabetes II Breakthrough Projects are funded by a ZonMw and Dutch Diabetes Research Foundation research call launched in 2018; project abstracts are available on the ZonMw website.
More information can be found at Research Net.